Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.16 is 24% below its 5-year average of 4.18, near the low end of its 5-year range (1.58–8.99).
17.67% above its 12-month average of 2.69.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
3.16
EARNINGS PER SHARE (EPS) AVG TTM
2.69
EARNINGS PER SHARE (EPS) AVG 3Y
4.37
EARNINGS PER SHARE (EPS) AVG 5Y
4.18
EARNINGS PER SHARE (EPS) AVG 10Y
3.51
EARNINGS PER SHARE (EPS) AVG 15Y
3.04
EARNINGS PER SHARE (EPS) AVG 20Y
3.31
CURRENT VS TTM AVG
+17.67%
CURRENT VS 3Y AVG
-27.64%
CURRENT VS 5Y AVG
-24.49%
CURRENT VS 10Y AVG
-10.00%
CURRENT VS 15Y AVG
+3.93%
CURRENT VS 20Y AVG
-4.41%
Market Cap
$102.88B
Earnings Per Share (EPS)
37.37
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
Market Cap
$89.76B
Earnings Per Share (EPS)
29.87
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$86.56B
Earnings Per Share (EPS)
22.50
TTM Avg
25.49
3Y Avg
25.23
5Y Avg
24.07
Market Cap
$82.21B
Earnings Per Share (EPS)
40.43
TTM Avg
41.98
3Y Avg
40.38
5Y Avg
45.10
Market Cap
$120.86B
Earnings Per Share (EPS)
3.78
TTM Avg
2.53
3Y Avg
3.71
5Y Avg
4.39
Market Cap
$76.43B
Earnings Per Share (EPS)
2.46
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
0.89
Market Cap
$73.30B
Earnings Per Share (EPS)
24.16
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GSK plc (GSK) | $100.78B | 3.16 | 2.69 | 4.37 | 4.18 |
| McKesson Corporation (MCK)vs › | $102.88B | 37.37 | 32.20 | 28.04 | 15.41 |
| HCA Healthcare, Inc. (HCA)vs › | $89.76B | 29.87 | 25.45 | 22.39 | 20.36 |
| Elevance Health Inc. (ELV)vs › | $86.56B | 22.50 | 25.49 | 25.23 | 24.07 |
| Medtronic plc (MDT)vs › | $116.18B | 3.73 | 3.69 | 3.25 | 3.23 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $82.21B | 40.43 | 41.98 | 40.38 | 45.10 |
| CVS Health Corp. (CVS)vs › | $120.86B | 3.78 | 2.53 | 3.71 | 4.39 |
| Boston Scientific Corporation (BSX)vs › | $76.43B | 2.46 | 1.61 | 1.19 | 0.89 |
| Cigna Corporation (CI)vs › | $73.30B | 24.16 | 17.27 | 18.45 | 18.81 |
| Bristol-Myers Squibb Company (BMY)vs › | $130.12B | 4.54 | -0.48 | 1.47 | 0.84 |
Trailing EPS (TTM)
$3.16
Forward EPS (Est.)
$3.58
P/E Ratio
16.1
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 3.79 |
| 2024-12-31 | 1.58 |
| 2023-12-31 | 3.10 |
| 2022-12-31 | 8.99 |
| 2021-12-31 | 3.71 |
| 2020-12-31 | 3.93 |
| 2019-12-31 | 3.10 |
| 2018-12-31 | 2.34 |
| 2017-12-31 | 1.05 |
| 2016-12-31 | 0.59 |
| 2015-12-31 | 6.42 |
| 2014-12-31 | 2.24 |
| 2013-12-31 | 4.67 |
| 2012-12-31 | 3.74 |
| 2011-12-31 | 4.07 |
| 2010-12-31 | 1.25 |
| 2009-12-31 | 4.40 |
| 2008-12-31 | 3.23 |
| 2007-12-31 | 4.68 |
| 2006-12-31 | 4.66 |
| 2005-12-31 | 3.54 |
| 2004-12-31 | 3.26 |
| 2003-12-31 | 3.46 |
| 2002-12-31 | 2.67 |
| 2001-12-31 | 1.83 |
| 2000-12-31 | 2.54 |
| 1999-12-31 | 2.03 |
| 1998-12-31 | 2.13 |
| 1997-12-31 | 2.15 |
| 1996-12-31 | 2.43 |
Reported annual fiscal-period values; no daily interpolation.
